Montag A & Associates Inc. Has $614,000 Stake in Danaher Corporation (DHR)

Montag A & Associates Inc. raised its stake in shares of Danaher Corporation (NYSE:DHR) by 11.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,155 shares of the conglomerate’s stock after buying an additional 728 shares during the quarter. Montag A & Associates Inc.’s holdings in Danaher were worth $614,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of DHR. BlackRock Inc. lifted its holdings in shares of Danaher by 2,530.9% during the 1st quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock valued at $3,247,398,000 after purchasing an additional 36,524,795 shares in the last quarter. Flossbach Von Storch AG lifted its holdings in shares of Danaher by 44.7% during the 2nd quarter. Flossbach Von Storch AG now owns 5,782,019 shares of the conglomerate’s stock valued at $487,945,000 after purchasing an additional 1,785,810 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Danaher by 3.9% during the 1st quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock valued at $3,503,962,000 after purchasing an additional 1,530,015 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Danaher by 16,410.0% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,485,901 shares of the conglomerate’s stock valued at $125,395,000 after purchasing an additional 1,476,901 shares in the last quarter. Finally, Koch Industries Inc. lifted its holdings in shares of Danaher by 29,127.3% during the 2nd quarter. Koch Industries Inc. now owns 1,404,665 shares of the conglomerate’s stock valued at $1,388,000 after purchasing an additional 1,399,859 shares in the last quarter. Institutional investors own 75.56% of the company’s stock.

Several equities analysts have recently weighed in on DHR shares. BidaskClub cut Danaher from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 1st. Jefferies Group LLC reiterated a “buy” rating and set a $95.00 price objective on shares of Danaher in a report on Friday, August 4th. J P Morgan Chase & Co reiterated an “overweight” rating and set a $95.00 price objective on shares of Danaher in a report on Friday, September 8th. Goldman Sachs Group Inc reiterated a “neutral” rating and set a $83.00 price objective on shares of Danaher in a report on Tuesday, September 26th. Finally, Cowen Inc reiterated a “buy” rating and set a $90.00 price objective on shares of Danaher in a report on Wednesday, October 4th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Danaher has an average rating of “Buy” and a consensus price target of $93.31.

In other Danaher news, SVP Daniel Raskas sold 37,870 shares of the business’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $93.33, for a total transaction of $3,534,407.10. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider William King sold 43,688 shares of the business’s stock in a transaction that occurred on Thursday, August 31st. The stock was sold at an average price of $82.86, for a total value of $3,619,987.68. Following the transaction, the insider now directly owns 45,748 shares in the company, valued at approximately $3,790,679.28. The disclosure for this sale can be found here. Insiders sold a total of 317,498 shares of company stock worth $28,838,801 in the last 90 days. Company insiders own 12.20% of the company’s stock.

Shares of Danaher Corporation (DHR) opened at $94.02 on Friday. The company has a market capitalization of $65,400.78, a P/E ratio of 24.17, a price-to-earnings-growth ratio of 2.24 and a beta of 1.02. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. Danaher Corporation has a 12 month low of $76.27 and a 12 month high of $94.24.

Danaher (NYSE:DHR) last released its earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The firm had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Danaher had a return on equity of 11.29% and a net margin of 13.36%. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.87 EPS. equities research analysts expect that Danaher Corporation will post 3.99 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were paid a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.60%. The ex-dividend date of this dividend was Thursday, September 28th. Danaher’s payout ratio is 16.52%.

TRADEMARK VIOLATION NOTICE: This article was published by Transcript Daily and is the property of of Transcript Daily. If you are accessing this article on another site, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://transcriptdaily.com/2017/11/26/montag-a-associates-inc-has-614000-stake-in-danaher-corporation-dhr.html.

Danaher Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply